Watch AEMD. Know when insiders buy.
One email the day a filing lands. Free.
AEMD
AETHLON MEDICAL INC
1.82
−0.11 −5.70%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.3MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$6.9MNET CASH —52W 1.82 – 40.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2027 · Jun 30 | — | — | — | −$1.6M | −$1.5M | — | -4.02 | −$1.9M | $9K | −$1.9M | Aug 13 |
| Q4 2026 · Mar 31derived | — | — | — | −$1.9M | −$1.9M | — | 0.40 | −$1.8M | $2K | −$1.8M | Jun 10 |
| Q3 2026 · Dec 31 | — | — | — | −$2.1M | −$2M | — | -2.45 | −$1.9M | — | — | Feb 12 |
| Q2 2026 · Sep 30 | — | — | — | −$1.5M | −$1.5M | — | -3.74 | −$1.7M | — | — | Feb 12 |
| Q1 2026 · Jun 30 | — | — | — | −$1.8M | −$1.8M | — | -42.42 | −$1.7M | $0 | −$1.7M | Aug 13 |
| Q4 2025 · Mar 31derived | — | — | — | −$2M | −$6.3M | — | -37.42 | −$1.7M | −$2K | −$1.7M | Jun 10 |
| Q3 2025 · Dec 31 | — | — | — | −$1.8M | −$1.8M | — | -10.05 | −$2M | $2K | −$2M | Feb 12 |
| Q2 2025 · Sep 30 | — | — | — | −$2.9M | −$2.8M | — | -16.11 | −$2.2M | $0 | −$2.2M | Feb 12 |
| Q1 2025 · Jun 30 | — | — | — | −$2.6M | −$2.6M | — | -2.76 | −$1.7M | $0 | −$1.7M | Feb 12 |
| Q4 2024 · Mar 31derived | — | — | — | −$2.5M | −$2.4M | — | -34.92 | −$2.6M | $5K | −$2.6M | Jun 26 |
| Q3 2024 · Dec 31 | — | — | — | −$3.6M | −$3.5M | — | -1.37 | −$2.4M | $9K | −$2.4M | Feb 12 |
| Q2 2024 · Sep 30 | — | — | — | −$3.2M | −$3M | — | -1.22 | −$2.7M | $7K | −$2.7M | Feb 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Mar 31 | — | — | −$7.3M | −$7.2M | — | -10.61 | −$7M | $4K | −$7M | — | — |
| FY2025 · to Mar 31 | — | — | −$9.3M | −$13.4M | — | -85.77 | −$7.6M | $0 | −$7.6M | — | — |
| FY2024 · to Mar 31 | $0 | — | −$12.6M | −$12.2M | — | -38.87 | −$10.1M | $251K | −$10.4M | — | — |
| FY2023 · to Mar 31 | $574K | — | −$11.9M | −$12M | -2094.9% | -5.86 | −$10.5M | $943K | −$11.4M | — | — |
| FY2022 · to Mar 31 | $294K | — | −$10.4M | −$10.4M | -3540.9% | -0.71 | −$9.8M | $349K | −$10.1M | — | — |
| FY2021 · to Mar 31 | $659K | — | −$7.9M | −$7.9M | -1196.6% | -0.65 | −$6.8M | $60K | −$6.8M | — | — |
Every number comes from AETHLON MEDICAL INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.